Zhang Junxiong, Lai Zhongming, Zhang Zhongmin, Zheng Shuai
Department of Orthopaedics, The First Affiliated Hospital, Southern Medical University, Academy of Orthopaedics, Guangdong Province, Guangzhou, 510515, China.
Heliyon. 2024 May 22;10(11):e31664. doi: 10.1016/j.heliyon.2024.e31664. eCollection 2024 Jun 15.
Osteosarcoma is widely believed to be an osteogenic differentiation disorder. In recent years, to further understand this disease, a lot resources were poured into the potential link between differentiation defects and tumorigenesis. Long-term monitoring of the differentiation progress of osteosarcoma cells is of great importance. In order to better promote the research, we have developed a novel fluorescent probe called PTB-EDTA, which exhibits remarkable bio-compatibility and demonstrates high selectivity towards osteosarcoma cells. Not only is the PTB-EDTA is capable of live cell imaging while conventional histology requires to kill the cells, its fluorescence is also enhanced as the osteogenic differentiation proceeding. These properties make PTB-EDTA a promising tool for monitoring osteosarcoma cells.
骨肉瘤被广泛认为是一种成骨分化障碍疾病。近年来,为了进一步了解这种疾病,大量资源投入到分化缺陷与肿瘤发生之间的潜在联系研究中。长期监测骨肉瘤细胞的分化进程至关重要。为了更好地推动该研究,我们开发了一种名为PTB-EDTA的新型荧光探针,它具有出色的生物相容性,并且对骨肉瘤细胞表现出高选择性。PTB-EDTA不仅能够在活细胞成像,而传统组织学需要杀死细胞,而且随着成骨分化的进行其荧光还会增强。这些特性使PTB-EDTA成为监测骨肉瘤细胞的一种有前景的工具。